Myriad Genetics, Inc. (MYGN), a genetic and genomic tumor testing and precision medicine provider, and INTERLINK Care Management, ...

Ameera Shah-led Metropolis Healthcare Limited, India's second-largest and most respected pathology laboratory chain, today ...

SALT LAKE CITY, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic and genomic tumor testing and precision medicine, and INTERLINK Care Management, Inc.

A female swell shark gives birth to a pup without coming in contact with a male, and now scientists are wondering how this is even possible.

SAN JOSE, Calif. - San Jose Police say they’re testing more than 900 rape kits after receiving a federal grant for $2.5 ...

In 2001, a woman was dragged into a Pacific Beach alley and sexually assaulted at knifepoint. It took more than 20 years to ...

The number of adults and kids diagnosed with developmental disabilities is rising, with implications for those individuals ...

Five witnesses have testified in day two of the State v. James F. Wilson jury trial. The victim who was 17 at the time of her 1984 attack testified Tuesday in her alleged assailant's trial.

SALT LAKE CITY - Myriad Genetics , Inc. (NASDAQ: NASDAQ:MYGN), a company specializing in genetic testing and precision medicine with annual revenues of $824 million, has announced the issuance of two ...

In honor of Rare Disease Day on February 28, 2025, Morgan Lewis is publishing a series of posts on As Prescribed and Health ...

RNA-based medicines are one of the most promising ways to fight human disease, as demonstrated by the recent successes of RNA vaccines and double-stranded RNA (dsRNA) therapies. But while health care ...

While genetic testing rates for advanced ovarian cancer have increased, gaps in physician understanding and confidence in interpreting results may limit optimal biomarker-driven treatment and patient ...